Taro patents expiration

1. Flo-pred patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7799331 TARO Oral suspension of prednisolone acetate
Oct, 2028

(5 years from now)

Drugs and Companies using PREDNISOLONE ACETATE ingredient

Market Authorisation Date: 17 January, 2008

Treatment: Treatment of asthma; Treatment of allergic reactions


More Information on Dosage

FLO-PRED family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic